Drug To Prevent Premature Birth Divides Doctors, Insurers And FDA Experts
An expert panel convened by the FDA says the drug Makena should be withdrawn from the market because a review of its effectiveness shows it doesn't work. But OB-GYNS who prescribe the drug disagree.
Đọc thêm tại NPR
at January 24, 2020 at 11:23PM
Health & Science
Thứ Sáu, 24 tháng 1, 2020
Đăng ký:
Đăng Nhận xét (Atom)
0 nhận xét:
Đăng nhận xét